NM_024426.6(WT1):c.907A>G (p.Thr303Ala) AND multiple conditions

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jan 26, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003793942.1

Allele description [Variation Report for NM_024426.6(WT1):c.907A>G (p.Thr303Ala)]

NM_024426.6(WT1):c.907A>G (p.Thr303Ala)

Gene:

WT1:WT1 transcription factor [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

11p13

Genomic location:

Preferred name:

NM_024426.6(WT1):c.907A>G (p.Thr303Ala)

HGVS:

NC_000011.10:g.32417635T>C
NG_009272.1:g.22907A>G
NM_000378.6:c.907A>G
NM_001198551.2:c.256A>G
NM_001198552.2:c.256A>G
NM_001407044.1:c.907A>G
NM_001407045.1:c.907A>G
NM_001407046.1:c.907A>G
NM_001407047.1:c.784A>G
NM_001407048.1:c.907A>G
NM_001407049.1:c.907A>G
NM_001407050.1:c.784A>G
NM_001407051.1:c.145A>G
NM_024424.5:c.907A>G
NM_024425.2:c.892A>G
NM_024426.6:c.907A>GMANE SELECT
NP_000369.4:p.Thr303Ala
NP_001185480.1:p.Thr86Ala
NP_001185480.1:p.Thr86Ala
NP_001185481.1:p.Thr86Ala
NP_001393973.1:p.Thr303Ala
NP_001393974.1:p.Thr303Ala
NP_001393975.1:p.Thr303Ala
NP_001393976.1:p.Thr262Ala
NP_001393977.1:p.Thr303Ala
NP_001393978.1:p.Thr303Ala
NP_001393979.1:p.Thr262Ala
NP_001393980.1:p.Thr49Ala
NP_077742.3:p.Thr303Ala
NP_077743.2:p.Thr298Ala
NP_077744.3:p.Thr298Ala
NP_077744.4:p.Thr303Ala
LRG_525t1:c.892A>G
LRG_525t2:c.256A>G
LRG_525:g.22907A>G
LRG_525p1:p.Thr298Ala
LRG_525p2:p.Thr86Ala
NC_000011.9:g.32439181T>C
NM_001198551.1:c.256A>G
NM_024426.3:c.892A>G
NR_160306.1:n.1086A>G
NR_176266.1:n.1086A>G

Protein change:

T262A

Molecular consequence:

NM_000378.6:c.907A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001198551.2:c.256A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001198552.2:c.256A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407044.1:c.907A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407045.1:c.907A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407046.1:c.907A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407047.1:c.784A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407048.1:c.907A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407049.1:c.907A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407050.1:c.784A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407051.1:c.145A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_024424.5:c.907A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_024425.2:c.892A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_024426.6:c.907A>G - missense variant - [Sequence Ontology: SO:0001583]
NR_160306.1:n.1086A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_176266.1:n.1086A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:: Drash syndrome (DDS)
Synonyms:: WILMS TUMOR AND PSEUDO- OR TRUE HERMAPHRODITISM; Wilms tumor and pseudohermaphroditism; Nephropathy, wilms tumor, and genital anomalies; See all synonyms [MedGen]
Identifiers:: MONDO: MONDO:0008682; MedGen: C0950121; Orphanet: 220; OMIM: 194080

Name:: Frasier syndrome
Identifiers:: MONDO: MONDO:0007635; MeSH: D052159; MedGen: C0950122; Orphanet: 347; OMIM: 136680

Name:: Wilms tumor 1 (WT1)
Synonyms:: Wilms tumor, somatic
Identifiers:: MONDO: MONDO:0008679; MedGen: CN033288; Orphanet: 654; OMIM: 194070

Name:: 11p partial monosomy syndrome (WAGR)
Synonyms:: CHROMOSOME 11p13 DELETION SYNDROME; WAGR syndrome; WAGR Complex; See all synonyms [MedGen]
Identifiers:: MONDO: MONDO:0008681; MedGen: C0206115; Orphanet: 893; OMIM: 194072

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004582060	Invitae	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Jan 26, 2023)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004582060

Invitae

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Jan 26, 2023)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Invitae, SCV004582060.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This variant has not been reported in the literature in individuals affected with WT1-related conditions. This variant is present in population databases (rs762325377, gnomAD 0.0009%). This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 298 of the WT1 protein (p.Thr298Ala). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt WT1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Jun 9, 2024

ClinVar

Relating variation to medicine